Structural Analysis of the GPI Transamidase Complex

GPI 转酰胺酶复合物的结构分析

基本信息

  • 批准号:
    8196655
  • 负责人:
  • 金额:
    $ 25.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-06-01 至 2013-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Glycosylphosphatidylinositol (GPI)-anchored proteins (GPI-APs) are ubiquitous in eukaryotes. Examples of GPI-APs include folate receptor, acetylcholinesterase, renal dipeptidase and the variant surface glycoproteins of Trypanosoma brucei, the causative agent of African sleeping sickness. Inability to synthesize GPI-APs results in embryonic lethality in mammals. Defective GPI biosynthesis in multipotent hematopoietic human stem cells causes paroxysmal nocturnal hemoglobinuria, an acquired hemolytic disease. GPI-APs are needed for fungal cell viability and they are important in diseases such as trypanosomiasis, malaria and leishmaniasis that are caused by parasitic protozoa. The GPI assembly pathway is a drug target for fungal and protozoal diseases. GPI anchoring is catalyzed by GPI transamidase (GPIT), a 5-subunit membrane- bound complex located in the endoplasmic reticulum (ER). The catalytic subunit, Gpi8, shares homology with caspases; the functional role of the other subunits is unclear, but all are required for GPIT activity. Three of the non-catalytic subunits are over-expressed in certain cancers, indicating a link between GPIT and oncogenesis. In this R21 application we propose to initiate structure-function studies of the GPIT complex using electron microscopy and X-ray crystallography. We are ultimately interested in establishing the structural organization of GPIT, delineating the role of its subunits, and understanding how this important enzyme is regulated. In two specific aims we propose to (1) analyze the endogenous GPIT complex from yeast by electron microscopy and (2) express GPIT subunits and sub-complexes for X-ray crystallographic studies. Our efforts are expected to yield a medium-resolution structure of GPIT and pave the way for a future high-resolution structure of the intact complex. These studies will have high impact as there is no structural information on GPIT; also, results obtained here will shed light on other multi-subunit membrane bound enzymes in the ER such as oligosaccharyltransferase and signal peptidase that play a critical role in processing a wide range of ER-translocated proteins, including proteins destined for GPI anchoring, but whose functional architecture remains largely a mystery. PUBLIC HEALTH RELEVANCE: Glycosylphosphatidylinositol (GPI)-anchored proteins such as folate receptor and acetylcholinesterase are ubiquitous in eukaryotes. They are also key players in diseases caused by fungal pathogens and parasitic protozoa. GPI transamidase, the enzyme responsible for synthesizing GPI-anchored proteins, is a complex structure consisting of five components that are embedded in a biological membrane. We are interested in using applying the tools of modern structural biology to learn about the structure of this enzyme as a first step to understanding how it works.
描述(由申请人提供):糖基磷脂酰肌醇(GPI)锚定蛋白(GPI-AP)在真核生物中普遍存在。GPI-AP的实例包括叶酸受体、乙酰胆碱酯酶、肾二肽酶和非洲昏睡病的病原体布氏锥虫的变体表面糖蛋白。不能合成GPI-AP导致哺乳动物的胚胎死亡。多能造血干细胞中GPI生物合成缺陷导致阵发性睡眠性血红蛋白尿症,一种获得性溶血病。GPI-AP是真菌细胞活力所需的,并且它们在由寄生原生动物引起的疾病如锥虫病、疟疾和利什曼病中是重要的。GPI组装途径是真菌和原生动物疾病的药物靶标。 GPI锚定由GPI转酰胺酶(GPIT)催化,GPI转酰胺酶是位于内质网(ER)中的5亚基膜结合复合物。催化亚基Gpi 8与半胱天冬酶具有同源性;其他亚基的功能作用尚不清楚,但都是GPIT活性所需的。其中三种非催化亚基在某些癌症中过度表达,表明GPIT与肿瘤发生之间存在联系。 在这个R21应用程序中,我们建议使用电子显微镜和X射线晶体学启动GPIT复合物的结构-功能研究。我们最终感兴趣的是建立GPIT的结构组织,描绘其亚基的作用,并了解如何调节这种重要的酶。在两个具体的目标,我们建议(1)分析内源性GPIT复合物从酵母的电子显微镜和(2)表达GPIT亚基和亚复合物的X射线晶体学研究。我们的努力有望产生中等分辨率的GPIT结构,并为未来完整复杂的高分辨率结构铺平道路。 这些研究将产生很大的影响,因为没有GPIT的结构信息;此外,这里获得的结果将揭示ER中的其他多亚基膜结合酶,如寡糖基转移酶和信号肽酶,它们在加工广泛的ER易位蛋白中发挥关键作用,包括注定用于GPI锚定的蛋白质,但其功能结构在很大程度上仍然是一个谜。 公共卫生关系:糖基磷脂酰肌醇(GPI)锚定蛋白如叶酸受体和乙酰胆碱酯酶在真核生物中普遍存在。它们也是真菌病原体和寄生原生动物引起的疾病的关键参与者。GPI转酰胺酶是负责合成GPI锚定蛋白的酶,是由嵌入生物膜中的五种组分组成的复杂结构。我们有兴趣应用现代结构生物学的工具来了解这种酶的结构,作为了解它如何工作的第一步。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANANT K MENON其他文献

ANANT K MENON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANANT K MENON', 18)}}的其他基金

Scramblases for protein glycosylation
用于蛋白质糖基化的 Scramblases
  • 批准号:
    10420706
  • 财政年份:
    2022
  • 资助金额:
    $ 25.35万
  • 项目类别:
Molecular basis of congenital disorder of glycosylation type 1N
1N型先天性糖基化障碍的分子基础
  • 批准号:
    10700974
  • 财政年份:
    2022
  • 资助金额:
    $ 25.35万
  • 项目类别:
Molecular basis of congenital disorder of glycosylation type 1N
1N型先天性糖基化障碍的分子基础
  • 批准号:
    10510784
  • 财政年份:
    2022
  • 资助金额:
    $ 25.35万
  • 项目类别:
Scramblases for protein glycosylation
用于蛋白质糖基化的 Scramblases
  • 批准号:
    10600063
  • 财政年份:
    2022
  • 资助金额:
    $ 25.35万
  • 项目类别:
Rhodopsin-mediated phospholipid flipping
视紫红质介导的磷脂翻转
  • 批准号:
    8786659
  • 财政年份:
    2014
  • 资助金额:
    $ 25.35万
  • 项目类别:
Rhodopsin-mediated phospholipid flipping
视紫质介导的磷脂翻转
  • 批准号:
    8895952
  • 财政年份:
    2014
  • 资助金额:
    $ 25.35万
  • 项目类别:
Structural Analysis of the GPI Transamidase Complex
GPI 转酰胺酶复合物的结构分析
  • 批准号:
    8267601
  • 财政年份:
    2011
  • 资助金额:
    $ 25.35万
  • 项目类别:
Biosynthesis of Membrane Protein Glycolipid Anchors
膜蛋白糖脂锚的生物合成
  • 批准号:
    7938503
  • 财政年份:
    2009
  • 资助金额:
    $ 25.35万
  • 项目类别:
Phospholipid Flip-flop in Biogenic Membranes
生物膜中的磷脂触发器
  • 批准号:
    7080488
  • 财政年份:
    2005
  • 资助金额:
    $ 25.35万
  • 项目类别:
Phospholipid Flip-flop in Biogenic Membranes
生物膜中的磷脂触发器
  • 批准号:
    7255834
  • 财政年份:
    2005
  • 资助金额:
    $ 25.35万
  • 项目类别:

相似海外基金

Effect of Acetylcholinesterase inhibitors on Bone Metabolism and Fracture Risk Factors among older adults with mild to moderate Alzheimer's Disease
乙酰胆碱酯酶抑制剂对患有轻至中度阿尔茨海默病的老年人骨代谢和骨折危险因素的影响
  • 批准号:
    10739853
  • 财政年份:
    2023
  • 资助金额:
    $ 25.35万
  • 项目类别:
Acetylcholinesterase Complex Protein-Protein Interactions as Drug Targets Against Organophosphate-induced Neurotoxicity.
乙酰胆碱酯酶复合物蛋白质-蛋白质相互作用作为抗有机磷诱导的神经毒性的药物靶点。
  • 批准号:
    10772738
  • 财政年份:
    2023
  • 资助金额:
    $ 25.35万
  • 项目类别:
Machine learning approaches to predict Acetylcholinesterase inhibition
预测乙酰胆碱酯酶抑制的机器学习方法
  • 批准号:
    10378934
  • 财政年份:
    2021
  • 资助金额:
    $ 25.35万
  • 项目类别:
Acetylcholinesterase Complex Protein-Protein Interactions as Drug Targets Against Organophosphate-induced Neurotoxicity.
乙酰胆碱酯酶复合物蛋白质-蛋白质相互作用作为抗有机磷诱导的神经毒性的药物靶点。
  • 批准号:
    10303546
  • 财政年份:
    2021
  • 资助金额:
    $ 25.35万
  • 项目类别:
Investigating the in vivo targets and mechanism of action of a toxic acetylcholinesterase-derived peptide upregulated in Alzheimer's disease
研究阿尔茨海默病中上调的有毒乙酰胆碱酯酶衍生肽的体内靶点和作用机制
  • 批准号:
    2480200
  • 财政年份:
    2020
  • 资助金额:
    $ 25.35万
  • 项目类别:
    Studentship
Improved Therapeutics for the Resurrection of the Aged Form of Acetylcholinesterase
老化乙酰胆碱酯酶复活的改进疗法
  • 批准号:
    9977281
  • 财政年份:
    2019
  • 资助金额:
    $ 25.35万
  • 项目类别:
Improved Therapeutics for the Resurrection of the Aged Form of Acetylcholinesterase
老化乙酰胆碱酯酶复活的改进疗法
  • 批准号:
    10238898
  • 财政年份:
    2019
  • 资助金额:
    $ 25.35万
  • 项目类别:
Elucidation of the cell protective mechanism of acetylcholinesterase variants in cardiomyocyte and approach to therapy for myocardial infarction
心肌细胞乙酰胆碱酯酶变异体的细胞保护机制的阐明及心肌梗死的治疗方法
  • 批准号:
    18K15850
  • 财政年份:
    2018
  • 资助金额:
    $ 25.35万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Alzheimer's disease drugs inhibiting acetylcholinesterase on prion replication.
阿尔茨海默病药物抑制乙酰胆碱酯酶对朊病毒复制的影响。
  • 批准号:
    481759-2015
  • 财政年份:
    2015
  • 资助金额:
    $ 25.35万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Reactivation of Aged Acetylcholinesterase: Design and Development of Novel Therap
老化乙酰胆碱酯酶的重新激活:新型疗法的设计和开发
  • 批准号:
    8735550
  • 财政年份:
    2014
  • 资助金额:
    $ 25.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了